The market research report presents the global cardiac markers market segmentation by assay type (Troponin I and BNP), by diagnostic facility (Cardiac POC testing and cardiac laboratory testing) and by geography (Americas, EMEA and APAC). The report also includes an insightful analysis of the leading companies in the market such as Abbott Laboratories, Alere, Roche Diagnostics, and Siemens Healthcare Diagnostics.
Technavio has released a global market research report on cardiac markers market, which is expected to grow at a CAGR of around 10% between 2015 and 2019, owing to development of new CHF biomarkers, the growing market for POC testing, and the approval of stroke biomarkers. The Americas is a major revenue contributor to the global cardiac markers market, occupying around 47% market share, and is expected to reach over US $2 billion by 2019. The region witnesses increased prevalence of patients affected by cardiovascular diseases (CVDs).
Cardiac marker testing is used in arteriosclerosis, conjunctive heart failure, sudden cardiac arrest, and myocardial infraction. Cardiac markers provide reliable and efficient disease diagnosis because of high-sensitivity test kits, short turnaround time, high productivity, and easy operation of instruments.
With the introduction of highly-sensitive assays, new cardiac markers have gained grounds recently. Researchers have launched asymmetric dimethyl arginine cardiac marker for cardiovascular disease prognosis. It is a competitive inhibitor of nitric oxide synthase and biomarker level increases in cardiovascular problems such as atherosclerosis, hypertension, coronary artery disease, and chronic heart failure.
“POCs diagnostic tests are the preferred tools for diagnosis and are gaining popularity in patient treatment evaluation. The tests detect the enzymes released during heart failure and other critical cardiac conditions, and release creatine kinase, troponin, LDH isoenzymes, and BNP. These tests act as a catalyst for the development of preventive medicine because of rapid tests results and a high level of accuracy,” says Imran Mushtaq, Lead Analyst, Healthcare, Technavio Research.
Abbott Laboratories, Alere, Roche Diagnostics, and Siemens Healthcare Diagnostics are the major vendors in the global cardiac markers market. The regulatory clearance for cardiac marker testing products has increased the customer base for vendors in new emerging markets.
This market research study includes an in-depth analysis and market shares and sizes of the sub-segments and geography. A comprehensive analysis of the key companies, including their market shares, business overview, key financials, etc. is provided in this study. There are many key drivers, challenges, and opportunities that are discussed in detail.
A more detailed analysis is available in the Technavio report, Global Cardiac Markers Market 2015-2019.
https://www.technavio.com/%3Cp%3E%3Cu%3E%3Cem%3E%3Cstrong%3EWe%20can%20cu…
